These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28778197)

  • 1. Outcome after resection of Adrenocortical Carcinoma liver metastases: a retrospective study.
    Baur J; Büntemeyer TO; Megerle F; Deutschbein T; Spitzweg C; Quinkler M; Nawroth P; Kroiss M; Germer CT; Fassnacht M; Steger U;
    BMC Cancer; 2017 Aug; 17(1):522. PubMed ID: 28778197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of adrenocortical carcinoma liver metastasis: is it justified?
    Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
    Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of surgery in the management of recurrent adrenocortical carcinoma.
    Erdogan I; Deutschbein T; Jurowich C; Kroiss M; Ronchi C; Quinkler M; Waldmann J; Willenberg HS; Beuschlein F; Fottner C; Klose S; Heidemeier A; Brix D; Fenske W; Hahner S; Reibetanz J; Allolio B; Fassnacht M;
    J Clin Endocrinol Metab; 2013 Jan; 98(1):181-91. PubMed ID: 23150691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional study.
    Ayabe RI; Narayan RR; Ruff SM; Wach MM; Lo W; Nierop PMH; Steinberg SM; Ripley RT; Davis JL; Koerkamp BG; D'Angelica MI; Kingham TP; Jarnagin WR; Hernandez JM
    HPB (Oxford); 2020 Jan; 22(1):169-175. PubMed ID: 31447392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic adrenocortical carcinoma: results of 56 pulmonary metastasectomies in 24 patients.
    op den Winkel J; Pfannschmidt J; Muley T; Grünewald C; Dienemann H; Fassnacht M; Allolio B
    Ann Thorac Surg; 2011 Dec; 92(6):1965-70. PubMed ID: 22000277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma.
    Tran TB; Maithel SK; Pawlik TM; Wang TS; Hatzaras I; Phay JE; Fields RC; Weber SM; Sicklick JK; Yopp AC; Duh QY; Solorzano CC; Votanopoulos KI; Poultsides GA
    J Am Coll Surg; 2016 Dec; 223(6):794-803. PubMed ID: 27618748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic liver resection for non-colorectal non-neuroendocrine metastases: perioperative and oncologic outcomes.
    Aghayan DL; Kalinowski P; Kazaryan AM; Fretland ÅA; Sahakyan MA; Røsok BI; Pelanis E; Bjørnbeth BA; Edwin B
    World J Surg Oncol; 2019 Sep; 17(1):156. PubMed ID: 31484583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operative management for recurrent and metastatic adrenocortical carcinoma.
    Datrice NM; Langan RC; Ripley RT; Kemp CD; Steinberg SM; Wood BJ; Libutti SK; Fojo T; Schrump DS; Avital I
    J Surg Oncol; 2012 Jun; 105(7):709-13. PubMed ID: 22189845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operative intervention for recurrent adrenocortical cancer.
    Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
    Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma.
    Weitz J; Blumgart LH; Fong Y; Jarnagin WR; D'Angelica M; Harrison LE; DeMatteo RP
    Ann Surg; 2005 Feb; 241(2):269-76. PubMed ID: 15650637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical resection of synchronously metastatic adrenocortical cancer.
    Dy BM; Strajina V; Cayo AK; Richards ML; Farley DR; Grant CS; Harmsen WS; Evans DB; Grubbs EG; Bible KC; Young WF; Perrier ND; Que FG; Nagorney DM; Lee JE; Thompson GB
    Ann Surg Oncol; 2015 Jan; 22(1):146-51. PubMed ID: 25092161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
    Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
    Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver resection and ablation for metastatic adrenocortical carcinoma.
    Ripley RT; Kemp CD; Davis JL; Langan RC; Royal RE; Libutti SK; Steinberg SM; Wood BJ; Kammula US; Fojo T; Avital I
    Ann Surg Oncol; 2011 Jul; 18(7):1972-9. PubMed ID: 21301973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
    Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Score Predicting Overall Survival After Surgery for Synchronous Metastatic Adrenocortical Carcinoma: A Surveillance, Epidemiology, and End Result-Based Study.
    Wu K; Liu Z; Li X; Lu Y
    Am Surg; 2021 May; 87(5):805-811. PubMed ID: 33228399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical carcinoma surgery-surgical extent and approach.
    Vanbrugghe C; Lowery AJ; Golffier C; Taieb D; Sebag F
    Langenbecks Arch Surg; 2016 Nov; 401(7):991-997. PubMed ID: 27412357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database.
    Prendergast KM; Smith PM; Tran TB; Postlewait LM; Maithel SK; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Shirley LA; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Votanopoulos KI; Levine EA; Poultsides GA; Solórzano CC; Kiernan CM
    Surgery; 2020 Feb; 167(2):352-357. PubMed ID: 31272813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and prognosis in hepatectomy for colorectal cancer with centrally located liver metastasis.
    Kuo IM; Huang SF; Chiang JM; Yeh CY; Chan KM; Chen JS; Yu MC
    World J Surg Oncol; 2015 Mar; 13():92. PubMed ID: 25889950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
    Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
    Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.